All sites C00-96,D32-33,D42-43,D45-47,D76 1790 90.3 2.9 3.4 1.4 2.1
Mouth, pharynx C00-14 29 97.2 0.7 0.7 - 1.4
  Lip C00 3 100.0 - - - -
  Tongue C02 6 100.0 - - - -
  Mouth, other C03-06 9 100.0 - - - -
  Salivary glands C07-08 3 84.6 7.7 7.7 - -
  Pharynx C01,C09-14 9 95.5 - - - 4.5
Digestive organs C15-26 291 81.2 3.4 8.6 2.9 3.9
  Oesophagus C15 11 91.1 - - 7.1 1.8
  Stomach C16 23 93.1 0.9 2.6 1.7 1.7
  Small intestine C17 8 82.1 2.6 5.1 5.1 5.1
  Colon C18 106 94.7 - 2.8 0.4 2.1
  Rectum, rectosigmoid C19-20 44 96.3 - 2.7 0.5 0.5
  Anus C21 4 100.0 - - - -
  Liver C22 21 64.4 10.6 14.4 5.8 4.8
  Gallbladder, bile ducts C23-24 12 60.0 6.7 13.3 5.0 15.0
  Pancreas C25 56 50.9 11.5 24.0 6.5 7.2
  Other digestive organs C26 6 36.7 - 30.0 13.3 20.0
Respiratory organs C30-39 140 63.6 15.0 13.5 4.7 3.2
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 131 63.2 15.7 13.7 4.9 2.4
  Mediastinum, pleura C38 2 41.7 16.7 33.3 - 8.3
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 93 99.8 - - - 0.2
Skin, non-melanoma C44 72 99.7 - - 0.3 -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 16 97.5 2.5 - - -
Breast C50 611 99.6 0.2 0.0 0.1 0.1
Female genital organs C51-58 178 93.6 2.4 1.9 0.8 1.3
  Cervix uteri C53 18 98.9 - - 1.1 -
  Corpus uteri C54 84 99.5 - 0.2 - 0.2
  Uterus, other C55,C58 2 37.5 12.5 12.5 - 37.5
  Ovary C56 47 86.5 5.1 4.6 1.3 2.5
  Other female genital C51-52,C57 28 87.9 5.7 2.8 2.1 1.4
Urinary organs C64-68 70 86.4 1.1 6.3 3.1 3.1
  Kidney C64 36 84.1 0.5 9.3 3.3 2.7
  Bladder and urinary tract2 C65-68 34 88.8 1.8 2.9 2.9 3.5
Eye C69 2 75.0 - 16.7 8.3 -
Brain, central nervous system C70-72,D32-33,D42-43 71 96.3 - 2.5 - 1.1
Thyroid gland C73 30 94.7 3.3 0.7 0.7 0.7
Other endocrine glands C74-75 3 100.0 - - - -
Illdefined or unknown C76,C80 35 53.4 10.2 15.9 8.0 12.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 144 84.3 6.5 0.8 1.7 6.6
  Hodgkin lymphoma C81 7 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 71 97.2 1.1 0.3 0.3 1.1
  Malignant immunoproliferative diseases C88 1 80.0 20.0 - - -
  Myeloma and other plasma cell tumors C90 22 82.4 5.6 2.8 1.9 7.4
  Leukaemia C91-95 27 69.9 16.2 - 3.7 10.3
  Myelodysplastic syndromes D46 7 23.5 20.6 - 5.9 50.0
  Myeloproliferaitive neoplasms D45,D47 11 69.8 13.2 3.8 3.8 9.4
Not included above
  Carcinoma in situ of the breast D05 54 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 105 100.0 - - - -
  Borderline tumour of the ovary D39 16 91.4 - 2.5 - 6.2
  Basal cell carcinoma of the skin 580 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.